Global Asthma and COPD Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431945
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca
  • Boehringer Ingelheim Gmbh
  • Glaxosmithkline Plc
  • Merck & Co
  • Novartis AG
  • MORE
Asthma and COPD Market - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025, the global asthma and COPD market was valued at US$ 39,021.2 Mn in 2016, and is expected to reach US$ 56,507.7 Mn by 2025, expanding at a CAGR of 4.2% from 2017 to 2025.

Market Insights

Globally, asthma and COPD is one the leading chronic respiratory diseases, with high prevalence and increasing health care and economic burden. Thus, disease represent a lucrative market for pharmaceutical companies. COPD is rated to be the fourth most common cause of mortality, and expected to reach third position by 2030, in case the risk such as smoking, pollution is not addressed. Gradually over the period of time the treatment of asthma and COPD shows improvement, with novel drugs and treatment strategies, along with usage of non-pharmacologic treatment. It has being observed there is being surge in prevalence of asthma and COPD in developed and developing countries. In developed countries, there is being rise in prevalence of asthma due to lifestyle changes in terms of food habit, low level of exercise, etc., while in developing countries the prevalence is due to pollution and smoking.

The global asthma and COPD market is segmented by drug type into anti-inflammatory drugs, bronchodilator monotherapy and combination drugs. Anti-inflammatory drugs includes corticosteroids, anti-leukotrienes and monoclonal antibodies. Bronchodilator monotherapy includes short-acting beta2-agonist (SABAs) and long-acting beta2-agonist (LABAs) and anticholinergic drugs. Amongst all, combination therapy of long-acting beta2 agonist (LABA)/ inhaled corticosteroid (ICS) dominates the market. The combination therapy that include Symbicort (AstraZeneca), Advair (GlaxoSmithKline) is most preferred treatment against asthma/ COPD, due to better efficacy and less side effects.

As of the current market scenario, North America together dominate the global asthma and COPD market followed by the European market. Rising prevalence of asthma and COPD due to pollution, change in lifestyle, entry of generics and novel therapies in the market. Asia Pacific is anticipated to be the fastest growing market for the forecast period. Emerging economies such India, China due to industrialization, demographic changes, urbanization there is been rise in pollution thus increase in prevalence of asthma and COPD population.

Market Competition Assessment

Key players in the global asthma and COPD market are Novartis AG, Merck & Co, GlaxoSmithKline Plc, Boehringer Ingelheim Gmbh, Nycomed, Abbott Laboratories, AstraZeneca, Roche Holding AG, Teva Pharmaceutical Industries, Vectura Group, Pfizer Inc. and others.

Key Market Movements:
  • There is a rise in the prevalence of asthma and COPD in both developed and developing countries. In developed countries, the rise in prevalence is mainly due to lifestyle change such as smoking, while in developing countries rise is observed due to presence of most polluted cities in the world and inclusion of smoking in lifestyle
  • Introduction of novel technology, strong pipeline, and personalization of medicine is also expected to drive the growth of market.
  • With economic development in emerging economies, healthcare awareness, and high disposable income are some of the factors driving the developing countries
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca
  • Boehringer Ingelheim Gmbh
  • Glaxosmithkline Plc
  • Merck & Co
  • Novartis AG
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Asthma and COPD Market Portraiture
2.2 Global Asthma and COPD Market Share, by Drug type, 2016 Vs 2025 (Value %)
2.3 Global Asthma and COPD Market, by Geography, 2016 (Value %)

Chapter 3 Global Asthma and COPD Market Analysis
3.1 Global Asthma and COPD Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Asthma and COPD Market

Chapter 4 Global Asthma and COPD Market Analysis, by Drug Type, 2015-2025 (US$ Mn)
4.1 Introduction
4.2 Anti-inflammatory drugs
4.2.1 Corticosteroids
4.2.2 Anti-Leukotrienes
4.2.3 Monoclonal antibodies
4.3 Bronchodilator monotherapy
4.3.1 Short-acting beta2-agonist (SABAs)
4.3.2 Long-acting beta2-agonist (LABAs)
4.3.3 Anticholinergics
4.4 Combination drugs
4.5 Pipeline Analysis
4.5.1 Projected sales of Phase III Asthma/COPD Drugs estimated till 2025 (US$ Mn)
4.5.1.1 GSK/INNOVIVA Fluticasone Furoate + Umeclidinium + Vilanterol (COPD)
4.5.1.2 Novartis Fevipiprant (Asthma)
4.5.1.3 Astrazeneca Tralokinumab (Asthma)
4.5.1.4 AstraZeneca/Kyowa Hakko Kirin Benralizumab (Asthma)
4.5.1.5 AstraZeneca Budesonide + formoterol (COPD)
4.5.1.6 AstraZeneca Budesonide + formoterol + glycopyrrolate (COPD)
4.5.1.7 AB Science Masitinib (Asthma)
4.5.1.8 GlaxoSmithKline Vilanterol (COPD)
4.5.1.9 Regeneron/Sanofi Dupilumab (Asthma)
4.5.1.10 Sunovion Sun-101(COPD)
4.5.1.11 Theravance Biopharma/Mylan Revefenacin (COPD)
4.5.1.12 Others
4.5.2 Tabular Representation of Phase II and I Drugs

Chapter 5 Global Asthma and COPD Market, By Geography, 2015-2025 (US$ Mn)
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan, & Rest of APAC)
5.5 Latin America (Brazil, Mexico & Rest of LATAM)
5.6 Middle East and Africa (UAE, Saudi Arabia, South Africa)

Chapter 6 Company Profiles
6.1 Novartis AG
6.2 Merck & Co
6.3 Glaxosmithkline Plc
6.4 Boehringer Ingelheim Gmbh
6.5 Nycomed
6.6 Abbott Laboratories
6.7 AstraZeneca
6.8 Roche Holding AG
6.9 Teva Pharmaceutical Industries
6.10 Vectura Group
6.11 Pfizer Inc.

List of Figures
Fig. 1 Global Asthma and COPD Market: Research Methodology
Fig. 2 Global Asthma and COPD Market Share, by Product type, 2016 Vs 2025 (Value %)
Fig. 3 Global Asthma and COPD Market, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition: Global Asthma and COPD Market, by Geography
Fig. 5 Competitive Analysis: Key Players in Global Asthma and COPD Market
Fig. 6 Global HIV-1 Screening Tests Market, 2015 - 2025 (US$ Mn)
Fig. 7 Global ELISA Market, 2015 - 2025 (US$ Mn)
Fig. 8 Global Rapid Tests Market, 2015 - 2025 (US$ Mn)
Fig. 9 Global Home Access Dried Blood Spots Market, 2015 - 2025 (US$ Mn)
Fig. 10 Global Western Blot Tests Market, 2015 - 2025 (US$ Mn)
Fig. 11 Global Indirect Immunofluorescence Assays (IFA) Market, 2015 - 2025 (US$ Mn)
Fig. 12 Global Line Immunoassays Market, 2015 - 2025 (US$ Mn)
Fig. 13 Global Radio-Immunoprecipitation Assays Market, 2015 - 2025 (US$ Mn)
Fig. 14 Global P24 Antigen Market, 2015 - 2025 (US$ Mn)
Fig. 15 Global Qualitative PCR Test Market, 2015 - 2025 (US$ Mn)
Fig. 16 Global Viral Culture Market, 2015 - 2025 (US$ Mn)
Fig. 17 Global HIV-2 & Group O Diagnostic Tests Market, 2015 - 2025 (US$ Mn)
Fig. 18 Global Viral Load Tests Market, 2015 - 2025 (US$ Mn)
Fig. 19 Global CD4 Testing Market, 2015 - 2025 (US$ Mn)
Fig. 20 Global Early Infant Diagnostics Market, 2015 - 2025 (US$ Mn)
Fig. 21 Latin America Asthma and COPD Market, 2015 - 2025 (US$ Mn)
Fig. 22 Middle East & Africa Asthma and COPD Market, 2015 - 2025 (US$ Mn)

List of Tables
Table 1 Global Asthma and COPD Market, By Product Type 2015-2025 (US$ Mn)
Table 2 Global Antibody Tests Market, 2015-2025 (US$ Mn)
Table 1 Global HIV-1 Antibody Confirmatory Tests Market 2015-2025 (US$ Mn)
Table 1 Global Viral Identification testing Market 2015-2025 (US$ Mn)
Table 2 Global Asthma and COPD Market, by Geography, 2015 - 2025 (US$ Mn)
Table 3 North America Asthma and COPD Market, by Country, 2015 - 2025 (US$ Mn)
Table 4 Europe Asthma and COPD Market, by Country, 2015 - 2025 (US$ Mn)
Table 5 Asia-Pacific Asthma and COPD Market, by Country, 2015 - 2025 (US$ Mn)
Table 6 Abbott Laboratories: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 7 Abbvie Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 8 Alere Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 9 Apogee Flow Systems: Company Snapshot (Business Description; Financial Performance; Product Position Portfolio; News Coverage)
Table 10 Beckman Coulter, Inc.: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 11 Becton, Dickinson & Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 12 BD Biosciences: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Table 13 Bio-Rad Laboratories: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 14 BioMerieux: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 15 Bristol-Myers Squibb: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 16 Cepheid: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 17 Chembio Diagnostic Systems: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 18 Daktari Diagnostics: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 19 Gilead Sciences: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 20 Gilead Sciences: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 21 Merch & Co. Inc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 22 Mylan Inc: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Table 23 Janssen Therapeutics: Company Snapshot (Business Description; Financial Performance; Product Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Novartis AG
  • Merck & Co
  • Glaxosmithkline Plc
  • Boehringer Ingelheim Gmbh
  • Nycomed
  • Abbott Laboratories
  • AstraZeneca
  • Roche Holding AG
  • Teva Pharmaceutical Industries
  • Vectura Group
  • Pfizer Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll